Novel CDK4/6 lnhibitor, WXJ-8 -Exerts Anti-effects Through Cell Cycle in Breast Cancer

• Үндсэн зохиолчид: Jing Ji (Зохиогч), ZHEN ZHANG (Зохиогч), GUAN-CHUN LI (Зохиогч), LING-YI ZUO (Зохиогч), JIAO-JIAO ZHOU (Зохиогч), XIU-JUN WANG (Зохиогч), SHAO-JIE MA (Зохиогч), BIN LIU (Зохиогч), JIN-QING HAN (Зохиогч), XIAO HOU (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Polskie Towarzystwo Farmaceutyczne, 2023-11-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

The novel Abemaciclib derivative WXJ-8 may be a promising anti-tumour drug; however, its mechanism of action and clinical value need to be further verified in research. Cell cycle regulating systems are critical in parthenogenesis and progression. Because of its involvement in regulating cell cycle...